InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Adlai Nortye Ltd.

ANL Clue Score26
United States Fiscal year ends December CIK 0001944552
$15.62 +0.71% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $15.62 +48.62% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 29 Sep 2023. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2021Revenue45.7Operating income−8.6Net income−56.7EPS, diluted−2.23Fiscal year 2022Operating income−67.3Net income−58.8EPS, diluted−2.31Fiscal year 2023Revenue5.0Operating income−72.6Net income−109.2EPS, diluted−2.52Fiscal year 2024Operating income−52.9Net income−51.9EPS, diluted−0.54
FY2021FY2022FY2023FY2024
Revenue 45.7 n/a 5.0 n/a
Growth
Operating income −8.6 −67.3 −72.6 −52.9
Net income −56.7 −58.8 −109.2 −51.9
Growth
EPS, diluted −2.23 −2.31 −2.52 −0.54

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2021Operating margin−18.9%Net margin−124.0%Free cash flow margin−8.9%Fiscal year 2022Fiscal year 2023Operating margin−1,451.0%Net margin−2,184.6%Free cash flow margin−1,137.0%Fiscal year 2024
FY2021FY2022FY2023FY2024
Operating margin −18.9% n/a −1,451.0% n/a
Net margin −124.0% n/a −2,184.6% n/a
Free cash flow margin −8.9% n/a −1,137.0% n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2021Operating cash flow−3.0Capital expenditure−1.0Free cash flow−4.1Fiscal year 2022Operating cash flow−43.2Capital expenditure−1.2Free cash flow−44.5Fiscal year 2023Operating cash flow−56.7Capital expenditure−0.2Free cash flow−56.9Fiscal year 2024Operating cash flow−51.8Capital expenditure−0.2Free cash flow−52.0
FY2021FY2022FY2023FY2024
Operating cash flow −3.0 −43.2 −56.7 −51.8
Capital expenditure −1.0 −1.2 −0.2 −0.2
Free cash flow −4.1 −44.5 −56.9 −52.0
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2021Cash64.1Shareholders’ equity−185.4Fiscal year 2022Cash42.8Shareholders’ equity−241.3Fiscal year 2023Cash91.5Shareholders’ equity75.0Fiscal year 2024Cash60.9Shareholders’ equity25.5
FY2021FY2022FY2023FY2024
Cash 64.1 42.8 91.5 60.9
Shareholders’ equity −185.4 −241.3 75.0 25.5

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2024 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023† 31 Dec 2023 FY2024† 31 Dec 2024
Revenue and profit
45.7 n/a 5.0 n/a
Growth
42.1 54.5 58.2 44.9
n/a 13.0 15.3 10.0
−8.6 −67.3 −72.6 −52.9
Growth
−56.7 −58.8 −109.2 −51.9
n/a n/a 0.6 n/a
−56.7 −58.8 −109.2 −51.9
Growth
Per share
−2.23 −2.31 −2.52 −0.54
−2.23 −2.31 −2.52 −0.54
Growth
25.4 25.4 43.3 95.8
25.4 25.4 43.3 95.8
Growth +0.0% +70.4% +121.0%

† The diluted share count jumps at 2023 and 2024, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 4 of 4 years on file.